Thymic Tumors clinical trials at UC Davis

1 in progress, 0 open to eligible people

Showing trials for

  • Ivonescimab for the Treatment of Thymic Cancer

    “Volunteer for research and contribute to discoveries that may improve health care for you, your family, and your community!”

    Sorry, not currently recruiting here

    This phase II trial tests how well ivonescimab works in treating patients with thymic carcinoma. Immunotherapy with monoclonal antibodies, such as ivonescimab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread.

    Davis, California and other locations

Our lead scientists for Thymic Tumors research studies include .

Last updated: